AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| ASS | Buy Back Closing date extended to 27 April 2018 | 11/04/18 | ||
| ASS | Second Dividend announced by Octaviar Ltd liquidators (Price Sensitive) | PRICE SENSITIVE | 29/03/18 | |
| ASS | Off Market BuyBack Offer (Price Sensitive) | PRICE SENSITIVE | 21/03/18 | |
| ASS | Half Yearly Report 31 December 2017 (Price Sensitive) | PRICE SENSITIVE | 08/03/18 | |
| ASS | Notice Final Director's Interest - John Sergeant | 28/02/18 | ||
| ASS | Notice Initial Director's interest - Sarina Roppolo | 28/02/18 | ||
| ASS | Director's Declaration - Sarina Roppolo | 28/02/18 | ||
| ASS | Board Changes | 28/02/18 | ||
| ASS Buy Back Closing date extended to 27 April 2018 | |||
| 11/04/18 | |||
| ASS Second Dividend announced by Octaviar Ltd liquidators (Price Sensitive) | |||
| 29/03/18 | PRICE SENSITIVE | ||
| ASS Off Market BuyBack Offer (Price Sensitive) | |||
| 21/03/18 | PRICE SENSITIVE | ||
| ASS Half Yearly Report 31 December 2017 (Price Sensitive) | |||
| 08/03/18 | PRICE SENSITIVE | ||
| ASS Notice Final Director's Interest - John Sergeant | |||
| 28/02/18 | |||
| ASS Notice Initial Director's interest - Sarina Roppolo | |||
| 28/02/18 | |||
| ASS Director's Declaration - Sarina Roppolo | |||
| 28/02/18 | |||
| ASS Board Changes | |||
| 28/02/18 | |||
